For most of their lives, Upper Hutt brothers Alec and Ronan Gall have used the blue Vento-lin inhalers familiar to several generations of New Zealanders to relieve their asthma symptoms.
But over the past year, Alec, 14, and Ronan, 11, have been using a different inhaler, Symbicort, which both relieves and helps prevent the symptoms. Symbicort is now the recommended first-line treatment to relieve symptoms in adolescents and adults after clinical trials by the Medical Research Institute of New Zealand (MRINZ) found it reduced the incidence of severe asthma attacks by between a third and a half.
Under current asthma guidelines, Symbicort is not yet recommended for children with mild asthma who, as with adults, account for most asthma cases. Instead, their recommended treatment is Ventolin or a similar inhaler called Respigen. However, that may eventually change, thanks to the efforts of Alec, Ronan and another 378 young people aged 5 to 15 taking part in an MRINZ clinical trial comparing the effectiveness of Ventolin and Symbicort in children with mild asthma.
The Children’s Anti-inflammatory Reliever (CARE) study has already recruited more than 200 participants and has now started recruiting in Auckland. Each participant is randomly assigned to use either a Ventolin or a Symbicort inhaler for a year whenever they have asthma symptoms. During the study, researchers meet with the participants five times (three times in person and twice remotely) to check how they’re going.
“It’s quite easy and not at all onerous,” says the boys’ mother, Louise Gall. “In terms of the paperwork, it’s just really noting down if the kids have had doctors’ appointments and what they’ve had the appointments for.”
FINANCIAL TOLL
Denne historien er fra November 05, 2022-utgaven av New Zealand Listener.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent ? Logg på
Denne historien er fra November 05, 2022-utgaven av New Zealand Listener.
Start din 7-dagers gratis prøveperiode på Magzter GOLD for å få tilgang til tusenvis av utvalgte premiumhistorier og 9000+ magasiner og aviser.
Allerede abonnent? Logg på
First-world problem
Harrowing tales of migrants attempting to enter the US highlight the political failure to fully tackle the problem.
Applying intelligence to AI
I call it the 'Terminator Effect', based on the premise that thinking machines took over the world.
Nazism rears its head
Smirky Höcke, with his penchant for waving with a suspiciously straight elbow and an open palm, won't get to be boss of either state.
Staying ahead of the game
Will the brave new world of bipartisanship that seems to be on offer with an Infrastructure Commission come to fruition?
Grasping the nettle
Broccoli is horrible. It smells, when being cooked, like cat pee.
Hangry? Eat breakfast
People who don't break their fast first thing in the morning report the least life satisfaction.
Chemical reaction
Nitrates in processed meats are well known to cause harm, but consumed from plant sources, their effect is quite different.
Me and my guitar
Australian guitarist Karin Schaupp sticks to the familiar for her Dunedin concerts.
Time is on my side
Age does not weary some of our much-loved musicians but what keeps them on the road?
The kids are not alright
Nuanced account details how China's blessed generation has been replaced by one consumed by fear and hopelessness.